M r Smith is a 45-year-old man at substantial risk for cardiovascular disease (CVD) because of the following laboratory findings: body mass index (BMI; calculated as the weight in kilograms divided by the height in meters squared), 29.5; resting blood pressure (BP), 130/85 mmHg; low-density lipoprotein cholesterol (LDL-C), 130 mg/dL (to convert to mmol/L, multiply by 0.0259); highdensity lipoprotein cholesterol (HDL-C), 38 mg/dL (to convert to mmol/L, multiply by 0.0259); triglycerides, 180 mg/dL (to convert to mmol/L, multiply by 0.0113); fasting blood glucose, 110 mg/dL (to convert to mmol/L, multiply by 0.0555); hemoglobin A1c, 6.4% (to convert to a proportion of total hemoglobin, multiply by 0.01); sedentary lifestyle; and poor dietary habits. However, Mr Smith has never smoked, and his family history does not indicate a genetic predisposition for hypertension, dyslipidemia, or CVD. Mr Smith is going to his primary care physician for a health assessment; he completes forms pertaining to general health information and insurance coverage and is brought to an examination room by a nurse, who measures his heart rate and BP. To this point, everything described is consistent with how health care in this setting has been conducted for decades. However, in the not too distant future, the following will take place next. The nurse then asks him to complete physical activity (PA)/ exercise training (ET) and dietary questionnaires, explaining that this is part of his vital signs assessment. The physician enters the room, exchanges some introductory dialogue, listens to heart sounds, and asks some standard questions pertaining to symptoms of CVD, of which there were none. The physician reviews Mr Smith’s questionnaire responses: (1) low daily PA (approximately 3000 steps per day), (2) not participating in regular ET, (3) high total fat intake (approximately 40%), and (4) high sodium intake (approximately 3000 mg/d). The conversation then quickly centers on PA, ET, and diet. Mr Smith shares more information regarding his predominantly sedentary lifestyle; the physician is acutely aware that this pattern is a significant health concern. He then provides more detail regarding his dietary habits, which the physician also recognizes to be rather poor and disconcerting. After Mr Smith answers all questions pertaining to these core lifestyle habits, the physician is ready to provide a diagnosis and care plan: “Mr Smith, you have poor lifestyle habits, which, if not treated immediately, will likely lead to the development of one or more noncommunicable diseases (NCDs).” The physician then explains to the patient that BP, cholesterol, and blood glucose medications may be unnecessary. To treat the patient’s condition, the healthy lifestyle team will prescribe the following medical interventions: (1) strategies to increase daily PA, (2) a regular ET program, (3) guidance on a healthy diet, and (4) behavioral strategies to optimize healthy lifestyle success. This programwill be individually tailored, and the patient will need to be an active participant in developing this plan. Mr Smith is then scheduled for appointments with 3 other members of the healthy lifestyle team, in this case an exercise physiologist, dietician, and behavioral counselor. Mr Smith has his appointments with the exercise physiologist, dietician, and behavioral counselor within the next week, all on the same day. The exercise physiologist performs an exercise test to assess aerobic capacity, which was 20% below the predicted norm. The exercise physiologist discusses the test results followed by a conversation regarding ways to increase daily PA and how to initiate an ET program with an ultimate goal of 150 minutes or more of moderate-intensity exercise per week. Mr Smith has a smartphone, and the exercise physiologist instructs him on how to use an application that allows for tracking of daily PA and the ET program. The dietician then meets with Mr Smith in the healthy lifestyle counseling From the Department of Physical Therapy and Integrative Physiology Laboratory, College of Applied Science, University of Illinois, Chicago (R.A.); and Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA (C.J.L.).